FDA Approves Continuous Glucose Monitoring System with 90-Day Implantable Sensor

The FDA has approved a continuous glucose monitoring (CGM) system with an implantable glucose sensor that can be worn for up to 90 days, as...

More From BioPortfolio on "FDA Approves Continuous Glucose Monitoring System with 90-Day Implantable Sensor"